Zeiss Medical Technology announced the 510k clearance from the US Food and Drug Administration (FDA) for Zeiss Clinic 360, an all-in-one cloud and browser-based software solution. According to a company press release, Zeiss Clinic 360 combines diagnostic and medical data into a comprehensive patient view that allows clinicians to evaluate disease progression, support treatment decisions, and improve workflow efficiency. Zeiss Clinic 360 is part of the Zeiss ophthalmic workflow portfolio and will be available in the US in early Fall 2026.
Zeiss Clinic 360 combines information from diagnostic devices, electronic medical records, and practice systems, into a comprehensive patient record that allows clinicians to view their Dicom-enabled diagnostic device data—including Cirrus, Clarus, and HFA from Zeiss, as well as third-party devices—to gain a unified, multi-modality view. Zeiss Clinic 360 also features EMR integration that consolidates critical patient data into the clinical workflow.
According to the company, Zeiss Clinic 360 leverages disease-based summaries, interactive analysis, and collaboration tools, and transforms data into actionable clinical insights. Clinicians can quickly monitor glaucoma progression, for example, with intuitive color-coded alerts and trend analysis of optical coherence tomography, intraocular pressure, and visual field data. When consultation is needed, clinicians can securely share cases and reports and request input from colleagues through integrated access to the Zeiss Collaborative Care feature, helping to facilitate improved patient care and referrals.
Built on the Zeiss Health Data Platform, Zeiss Clinic 360 is accessed through the cloud or a web-based browser, enabling clinicians to review information across locations without requiring local software installation. Subscription options allow practices to select the configuration that best aligns with their operational and clinical requirements, the company said in the press release. OM